Page last updated: 2024-08-24

3-iodobenzylguanidine and Minimal Disease, Residual

3-iodobenzylguanidine has been researched along with Minimal Disease, Residual in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (50.00)18.2507
2000's3 (25.00)29.6817
2010's2 (16.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Cho, HW; Cho, YS; Ju, HY; Koo, HH; Lee, JW; Lim, H; Seo, ES; Shin, M; Sung, KW; Yoo, KH1
McHugh, K; Orr, KE1
Allen-Rhoades, W; Kim, E; Krance, R; Louis, CU; Mazloom, A; Nuchtern, J; Paulino, AC; Russell, H1
Cammilleri, S; Colavolpe, C; Coze, C; Guedj, E; Mundler, O; Taïeb, D1
Aliberti, G; Bombardieri, E; Castellani, MR; Chiesa, C; Maccauro, M; Orunesu, E; Seregni, E1
Akhurst, TJ; Cheung, NK; Kramer, K; Kushner, BH; Modak, S1
Bertocchi, C; Mazzoni, A; Medolago, G; Moschini, L; Torre, L; Virotta, G; Zappone, C1
De Sio, L; Deb, G; Di Giuda, D; Donfrancesco, A; Giordano, A; Petrone, A; Rufini, V; Troncone, L1
Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S1
Bertolazzi, L; Cabria, M; Claudiani, F; Conte, M; De Bernardi, B; Garaventa, A; Nigro, M; Pianca, C; Stimamiglio, P; Villavecchia, GP1
De Kraker, J; Hoefnagel, CA; Valdés Olmos, RA; Voûte, PA1
Kuroda, T; Mizutani, S; Nakano, M; Saeki, M1

Reviews

2 review(s) available for 3-iodobenzylguanidine and Minimal Disease, Residual

ArticleYear
The new international neuroblastoma response criteria.
    Pediatric radiology, 2019, Volume: 49, Issue:11

    Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Child; Humans; Iodine Radioisotopes; Neoplasm, Residual; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms

2019
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2008, Volume: 52, Issue:4

    Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Humans; Neoplasm Metastasis; Neoplasm, Residual; Proto-Oncogene Mas; Recurrence; Thyroid Neoplasms

2008

Other Studies

10 other study(ies) available for 3-iodobenzylguanidine and Minimal Disease, Residual

ArticleYear
Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:7

    Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm, Residual; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous

2022
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
    International journal of radiation oncology, biology, physics, 2014, Nov-15, Volume: 90, Issue:4

    Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult

2014
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
    Pediatric blood & cancer, 2008, Volume: 51, Issue:6

    Topics: 3-Iodobenzylguanidine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome

2008
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Dura Mater; Etoposide; Femur; Humans; Infant; Iodine Radioisotopes; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Remission Induction; Skin Neoplasms

2009
Meta-[123I]iodobenzylguanidine single photon emission computed tomography in chemodectomas.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Papillary; Diagnosis, Differential; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Paraganglioma, Extra-Adrenal; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1995
[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Image Enhancement; Infant; Infant, Newborn; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1995
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Marrow Neoplasms; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Pheochromocytoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Survival Rate

1995
Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone Neoplasms; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Italy; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Prognosis; Radiopharmaceuticals; Remission Induction; Survival Rate; Thoracic Neoplasms

1995
[131I]MIBG as a first line treatment in advanced neuroblastoma.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance, Neoplasm; Feasibility Studies; Female; Humans; Infant; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm, Residual; Neuroblastoma; Postoperative Care; Radiopharmaceuticals; Remission Induction

1995
Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
    Journal of pediatric surgery, 1997, Volume: 32, Issue:1

    Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Transplantation; Child; False Negative Reactions; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neoplasm, Residual; Neoplastic Cells, Circulating; Neuroblastoma; Polymerase Chain Reaction; Prognosis; Risk Factors; RNA-Directed DNA Polymerase; RNA, Messenger; Sensitivity and Specificity; Tyrosine 3-Monooxygenase; Vanilmandelic Acid

1997